Vor Biopharma Inc (NAS:VOR)
$ 19.14 -0.61 (-3.09%) Market Cap: 1.04 Bil Enterprise Value: 548.53 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 32/100

Vor Biopharma Inc Annual Shareholders Meeting Transcript

Jun 14, 2022 / 04:00PM GMT
Release Date Price: $85.2 (-14.29%)
Robert Ang
VOR BIOPHARMA INC. - President, CEO & Director

Good morning. My name is Robert Ang, President and Chief Executive Officer and the Director of Vor Bio. I'm very happy to welcome you to the Vor Bio 2022 Annual Stockholder Meeting.

Before I call the meeting to order, I'd like to introduce you to the other members of the Board who are with us today, including Matthew Patterson and David Lubner. The other executive officers of Vor Bio here today are Tirtha Chakraborty and Nathan Jorgensen. Also present is Patrick Good of Ernst & Young, Vor Bio's auditor, who is available to respond to appropriate questions, and [Jenny oceanic] and [Tail Cos] of Cooley, Vor Bio's outside corporate counsel

I will be acting as Chairperson of this meeting. Nathan Jorgensen will act as Secretary of this meeting.

Thank you to Sarah Spencer, our Head of Communications for coordinating the meeting.

The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in your notice of annual meeting and proxy statement. After the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot